Design Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
48.53 |
117.33 |
204.78 |
10.00 |
54.00 |
| Przychód Δ r/r |
0.00% |
inf% |
141.78% |
74.53% |
-95.12% |
440.03% |
| Przychód (min) |
0.00 |
46.94 |
117.33 |
204.78 |
10.00 |
54.00 |
| Przychód (max) |
0.00 |
50.12 |
117.33 |
204.78 |
10.00 |
54.00 |
| EBITDA (średnia) |
0.00 |
29.12 |
70.40 |
122.87 |
6.00 |
32.40 |
| EBIT (średnia) |
0.00 |
29.12 |
70.40 |
122.87 |
6.00 |
32.40 |
| EBIT % |
0.00% |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-50.93 |
-75.26 |
-83.78 |
-71.02 |
-92.24 |
-74.41 |
| Zysk netto % |
-inf% |
-155.09% |
-71.40% |
-34.68% |
-922.37% |
-137.79% |
| EPS (średnia) |
-0.90 |
-1.33 |
-1.23 |
-1.25 |
-1.63 |
-1.31 |
| Liczba analityków (Przychody) |
0 |
2 |
2 |
1 |
1 |
1 |
| Liczba analityków (EPS) |
2 |
2 |
2 |
1 |
1 |
1 |
| symbol |
DSGN |
DSGN |
DSGN |
DSGN |
DSGN |
DSGN |